fbpx
QQQ
-2.19
326.60
-0.68%
DIA
-2.60
346.25
-0.76%
SPY
-3.50
419.02
-0.84%
TLT
-0.35
137.14
-0.26%
GLD
+ 0.33
174.37
+ 0.19%

Top 4 Large-Cap Stocks In The Drug Manufacturers Industry With The Highest ROE

by
April 6, 2015 4:46 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Below are the top large-cap drug manufacturers stocks on the NYSE and the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Shire plc (NASDAQ: SHPG) is 50.50%. Shire’s PEG ratio is 1.01.

The trailing-twelve-month return on equity at GlaxoSmithKline plc (NYSE: GSK) is 50.00%. GlaxoSmithKline’s EPS for the same period is $1.69.

The trailing-twelve-month return on equity at AbbVie Inc. (NYSE: ABBV) is 43.50%. AbbVie’s revenue for the same period is $19.96 billion.

The trailing-twelve-month return on equity at Merck & Co. Inc. (NYSE: MRK) is 24.80%. Merck’s EPS growth forecast for the next year is 12.59%.

Posted-In:

Trading Ideas

Related Articles

Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios

The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and selling. read more

Stocks That Hit 52-Week Highs On Friday

  During Friday's morning session, 127 stocks hit new 52-week highs. read more

Stocks That Hit 52-Week Highs On Friday

    On Friday morning, 417 companies achieved new highs for the year. read more

Stocks That Hit 52-Week Highs On Tuesday

    Before 10 a.m. ET on Tuesday, 166 companies hit new 52-week highs. read more